SARTORIUS
At today’s Sartorius AG Annual Shareholders’ Meeting in Goettingen, Germany, shareholders approved the board's proposals by a large majority. The Annual Shareholders' Meeting thus passed the resolution to pay dividends of 0.46 euros per preference share (previous year 0.381 euros) and 0.45 euros per ordinary share (previous year 0.371 euros). The total amount disbursed will rise by 20.5 % year over year from 25.8 million euros to 31.1 million euros. At 23.5 %, the payout ratio is at the level of the previous years (2015: 24.0 %).
During the regular election of shareholder representatives to the Supervisory Board, shareholders re-elected Dr. Lothar Kappich, Prof. Dr. Dres. h.c. Arnold Picot, Prof. Dr. Thomas Scheper and Prof. Dr. Klaus Rüdiger Trützschler. Dr. Daniela Favoccia, Partner of the lawyer’s office Hengeler Mueller, and Ilke Hildegard Panzer, Executive Vice President and Chief Innovation Officer of the BloodCenter of Wisconsin, part of the US-based Health Care-company Versiti Inc., were elected for the first time. The new Supervisory Board will serve for a term of five years.
Furthermore, the Annual Shareholders' Meeting granted discharge to the Supervisory Board and to the Executive Board by a considerable majority. On the whole, more than 500 share owners representing over 96 % of the voting share capital attended this year's Annual Shareholders' Meeting.
1 Adjusted for stock split; rounded values
This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties. This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.
Presentation Held by Dr. Joachim Kreuzburg at the Annual Shareholders' Meeting
You will find this presentation and further information on the ASM at: https://www.sartorius.com/sartorius/en/EUR/company/investor-relations/sartorius-ag/shareholders-meeting/2017
Current Image Files
Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG
www.sartorius.com/fileadmin/media/global/company/Sartorius_Kreuzburg.jpg
Sartorius products used in the manufacture of medications
https://www.sartorius.com/mediafile/corp/Sartorius_0232_PG9_01_RGB.jpg
Sartorius products used in biopharma research laboratories
www.sartorius.com/mediafile/corp/Sartorius_0424_PG14.jpg
Upcoming Financial Dates
April 24, 2017 Publication of first-quarter figures (January to March 2017)
July 25, 2017 Publication of the first-half figures (January to June 2017)
October 24, 2017 Publication of nine-month figures (January to September 2017)
A Profile of Sartorius
The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes. Founded in 1870, the company earned sales revenue of more than 1.3 billion euros in 2016. Approximately 7,000 people work at the Group's approximately 50 manufacturing and sales sites, serving customers around the globe.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170406005678/en/
Contact:
Sartorius
Petra Kirchhoff, Vice President of Corporate
Communications
+49 (0)551.308.1686
petra.kirchhoff@sartorius.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Esri ArcGIS Location PlatformAdds Session Usage Pricing for Basemaps8.10.2025 20:44:00 CEST | Press release
New Model Offers Predictable, Flexible Cost Structure for High-Traffic and Long-Session Applications Esri, the global leader in location intelligence, today announced the release of a new session usage pricing model for basemaps available through ArcGIS Location Platform. This session usage model complements the existing tile usage pricing, which customers will still have the option to choose based on their operational needs. Developers and organizations will now have a more predictable and cost-effective way to integrate Esri’s high-quality basemaps into their applications and business systems. The additional pricing option for ArcGIS Location Platform is especially valuable for high-traffic applications or those with extended user sessions, such as real estate search portals, rideshare apps, or delivery tracking systems. By aligning pricing with actual user interactions—such as panning, zooming, and searching—developers can better forecast costs. “Organizations struggle with unpredic
Forum Invest in Senegal 2025 (Fii Senegal 2025): President Bassirou Diomaye Faye Calls for Investment in a Transforming Senegal8.10.2025 19:50:00 CEST | Press release
“Senegal offers a growing market within the framework of the Continental Free Trade Area, supported by a legal environment undergoing modernization and reform. We are ready to welcome you and facilitate your establishment and success. Come seize opportunities in high-potential strategic sectors and forge fruitful, mutually beneficial partnerships,” stated His Excellency President Bassirou Diomaye Faye at the opening of Forum Invest in Senegal 2025 (Fii Senegal 2025) (https://FiiSenegal.sn/). With these words, the Head of State set the tone for a forward-looking forum, symbolizing a Senegal firmly committed to the path of economic transformation, stability, and trust. The President reiterated the four pillars of Vision Senegal 2050—economic diversification, regional development, strengthened governance, and investment in human capital—as the guiding framework for the country’s long-term development. Following this, Bakary Séga Bathily, Director General of APIX, welcomed this direction,
Bacardi Legacy of Great Workplace Continues With Forbes Honor of “World’s Best Employers” in 20258.10.2025 17:25:00 CEST | Press release
Family-Owned Company Earns Top Rank Within Spirits Bacardi Limited is proud to once again land a spot on the Forbes’ list of the ‘World’s Best Employers 2025’ — proving that great people and a great culture never go out of style. The family-owned company is a repeat show on the global list which is based on more than 300,000 independent surveys conducted in more than 50 countries. Participants were asked whether they would recommend a company to family or friends, and to rate it based on such criteria as workplace environment, salary, and other key criteria. Bacardi, the world’s largest privately held international spirits company, earned the highest ranking of pure spirits companies coming in at #86. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251008919280/en/ Bacardi legacy of great workplace continues. “Being recognized again by Forbes among the World’s Top Employers is a true testament to our culture and the dedicatio
DevvStream Reports BTC and SOL Reserves as Crypto-Treasury Program Accelerates8.10.2025 17:00:00 CEST | Press release
DevvStream Corp. (Nasdaq: DEVS) (“DevvStream” or the “Company”), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, today reported current holdings and progress under its crypto-treasury program, which is designed to add 24/7 liquidity and generate staking income. Portfolio snapshot (BitGo custody): Bitcoin ($BTC): approximately 22.229 BTC held, valued at (US) $2,716,162 as of October 7, 2025. Solana ($SOL): 12,110.98 SOL acquired year-to-date; 12,127.64 SOL staked, including rewards. Total SOL held is valued at (US) $2,718,489 as of October 7, 2025. USD balance: approximately (US) $1,280,000 in cash within BitGo. The Company has retained all digital-asset holdings accumulated under the program to date. The treasury is intended to create incremental income through SOL staking and establish on-chain readiness for tokenized real-world assets, including renewable-energy plants, energy-trading contracts, and other sustainability
Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product8.10.2025 16:51:00 CEST | Press release
A pioneer in modified risk tobacco products, Philip Morris International is the only company to have received a modified risk marketing claim for an electronic nicotine device. FDA concludes “Evidence continues to support the modified exposure claim that ‘Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals.’” Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP). The full-day meeting on October 7 was part of the FDA’s customary review of PMI’s request to continue marketing versions of its IQOS heated tobacco products in the U.S. as modified risk tobacco products (MRTPs), a necessary ste
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom